Tuberculosis pathogenesis and immunity

Annual Review of Pathology: Mechanisms of Disease

Volumn 7, Issue , 2012, Pages 353-384

  Philips, Jennifer A ^a   Ernst, Joel D ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immunity; Granuloma; Immune evasion; Innate immunity; Mycobacterium tuberculosis; Phagosome maturation

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD11B ANTIGEN; CD18 ANTIGEN; COLECALCIFEROL; DECTIN 1; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTEGRIN; INTERFERON; INTERLEUKIN 10; MANNOSE BINDING LECTIN; RAB7 PROTEIN; REACTIVE NITROGEN SPECIES; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR 2; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; VACCINE; VITAMIN D;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; AUTOPHAGY; BACTERIAL CELL WALL; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; DENDRITIC CELL; GRANULOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MIXED INFECTION; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VITAMIN D DEFICIENCY;

ADAPTIVE IMMUNITY; HUMANS; IMMUNITY, INNATE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84856843927     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-011811-132458     Document Type: Review

References (169)

1. Wolf AJ, Linas B, Trevejo-Nuñez GJ, Kincaid E, Tamura T, et al. 2007. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179:2509-19
2. Sch'afer G, Jacobs M, Wilkinson RJ, Brown GD. 2009. Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes. J. Innate Immun. 1:231-43
3. Briken V, Porcelli SA, Besra GS, Kremer L. 2004. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol. Microbiol. 53:391-403 (Pubitemid 38998163)
4. CourtN, Vasseur V, Vacher R, Fŕemond C, Shebzukhov Y, et al. 2010. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J. Immunol. 184:7057-70
5. Ehlers S. 2010. DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. Eur. J. Cell Biol. 89:95-101
6. Appelmelk BJ, den Dunnen J, Driessen NN, Ummels R, Pak M, et al. 2008. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol. 10:930-44 (Pubitemid 351386948)
7. Driessen NN, Ummels R, Maaskant JJ, Gurcha SS, Besra GS, et al. 2009. Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. Infect. Immun. 77:4538-47
8. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, et al. 2009. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206:2879-88
9. Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, et al. 2010. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 184:2756-60
10. Zimmerli S, Edwards S, Ernst JD. 1996. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am. J. Respir. CellMol. Biol. 15:760-70 (Pubitemid 126441449)
11. Philips JA, Rubin EJ, Perrimon N. 2005. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309:1251-53 (Pubitemid 41170920)
12. Sch'afer G, Guler R, Murray G, Brombacher F, Brown GD. 2009. The role of scavenger receptor B1 in infection with Mycobacterium tuberculosis in a murine model. PLoS ONE 4:e8448
13. Hawkes M, Li X, Crockett M, Diassiti A, Finney C, et al. 2010. CD36 deficiency attenuates experimental mycobacterial infection. BMC Infect. Dis. 10:299
14. Hu C, Mayadas-Norton T, Tanaka K, Chan J, Salgame P. 2000. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J. Immunol. 165:2596-602 (Pubitemid 30660706)
15. Kang PB, Azad AK, Torrelles JB, Kaufman TM, Beharka A, et al. 2005. The human macrophagemannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 202:987-99 (Pubitemid 41396898)
16. Armstrong JA, Hart PD. 1975. Phagosome-lysosome interactions in cultured macrophages in- fected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142:1-16
17. McDonough KA, Kress Y, Bloom BR. 1993. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 61:2763-73 (Pubitemid 23182267)
18. Van Der Wel N, Hava D, Houben D, Fluitsma D, van Zon M, et al. 2007. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129:1287-98 (Pubitemid 46962098)
19. Armstrong JA, Hart PD. 1971. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134:713-40
20. Russell DG. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2:569-77 (Pubitemid 33674008)
21. Philips JA. 2008. Mycobacterial manipulation of vacuolar sorting. Cell Microbiol. 10:2408-15
22. Bach H, Papavinasasundaram KG, Wong D, Hmama Z, Av-Gay Y. 2008. Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3:316-22 (Pubitemid 351635998)
23. Sun J, Wang X, Lau A, Liao TY, Bucci C, Hmama Z. 2010. Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages. PLoS ONE 5:e8769
24. Vergne I, Chua J, Lee HH, Lucas M, Belisle J, DereticV. 2005. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102:4033-38 (Pubitemid 40388550)
25. Purdy GE, Owens RM, Bennett L, Russell DG, Butcher BA. 2005. Kinetics of phosphatidylinositol-3- phosphate acquisition differ between IgG bead-containing phagosomes and Mycobacterium tuberculosis- containing phagosomes. Cell Microbiol. 7:1627-34 (Pubitemid 41511919)
26. VieiraOV, HarrisonRE, Scott CC, Stenmark H, AlexanderD, et al. 2004. Acquisition of Hrs, an essential component of phagosomal maturation, is impaired by mycobacteria. Mol. Cell. Biol. 24:4593-604 (Pubitemid 44109141)
27. Kusner DJ. 2005. Mechanisms of mycobacterial persistence in tuberculosis. Clin. Immunol. 114:239-47 (Pubitemid 40255129)
28. Festjens N, Bogaert P, Batni A, Houthuys E, Plets E, et al. 2011. Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine againstM. tuberculosis. EMBOMol. Med. 3:222-34
29. Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V. 2001. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J. Cell Biol. 154:631-44 (Pubitemid 34286167)
30. Philips JA, Porto MC, Wang H, Rubin EJ, Perrimon N. 2008. ESCRT factors restrict mycobacterial growth. Proc. Natl. Acad. Sci. USA 105:3070-75 (Pubitemid 351723669)
31. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753-66 (Pubitemid 40017683)
32. Fratti RA, Chua J, Vergne I, Deretic V. 2003. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. USA 100:5437-42 (Pubitemid 36542723)
33. Indrigo J, Hunter RL Jr, Actor JK. 2003. Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149:2049-59 (Pubitemid 37038411)
34. Armstrong JA, Hart PD. 1975. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142:1-16
35. VandalOH, Nathan CF, Ehrt S. 2009. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol. 191:4714-21
36. Abdallah AM, Gey van Pittius NC, Champion PA, Cox J, Luirink J, et al. 2007. Type VII secretion- mycobacteria show the way. Nat. Rev. Microbiol. 5:883-91 (Pubitemid 47578389)
37. Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, et al. 2004. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol. Microbiol. 51:359-70 (Pubitemid 38142126)
38. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, et al. 2003. The primary mechanism of attenuation of bacillus Calmette-Gúerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc. Natl. Acad. Sci. USA 100:12420-25 (Pubitemid 37271575)
39. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. 2002. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovisBCGand Mycobacteriummicroti. Mol. Microbiol. 46:709-17 (Pubitemid 35365606)
40. Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, Brown EJ. 2004. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol. Microbiol. 53:1677-93 (Pubitemid 39265314)
41. Smith J, Manoranjan J, Pan M, Bohsali A, Xu J, et al. 2008. Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole. Infect. Immun. 76:5478-87
42. de Jonge MI, Pehau-Arnaudet G, Fretz MM, Romain F, Bottai D, et al. 2007. ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. J. Bacteriol. 189:6028-34 (Pubitemid 47236155)
43. MacGurn JA, Cox JS. 2007. A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system Infect. Immun. 75:2668-78 (Pubitemid 46870147)
44. Tan T, Lee WL, Alexander DC, Grinstein S, Liu J. 2006. The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation. Cell Microbiol. 8:1417-29 (Pubitemid 44194575)
45. Xu J, Laine O, Masciocchi M, Manoranjan J, Smith J, et al. 2007. A unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. Mol. Microbiol. 66:787-800 (Pubitemid 47621863)
46. Garces A, Atmakuri K, Chase MR, Woodworth JS, Krastins B, et al. 2010. EspA acts as a critical mediator of ESX1-dependent virulence in Mycobacterium tuberculosis by affecting bacterial cell wall integrity. PLoS Pathog. 6:e1000957
47. Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, et al. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5:e1000500
48. Stanley SA, Johndrow JE, Manzanillo P, Cox JS. 2007. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178:3143-52 (Pubitemid 46333196)
49. Coulombe F, Divangahi M, Veyrier F, de Leseleuc L, Gleason JL, et al. 2009. IncreasedNOD2-mediated recognition of N-glycolyl muramyl dipeptide. J. Exp. Med. 206:1709-16
50. Koo IC, Wang C, Raghavan S, Morisaki JH, Cox JS, Brown EJ. 2008. ESX-1-dependent cytolysis in lysosome secretion and inflammasome activation duringmycobacterial infection. CellMicrobiol. 10:1866-78
51. Mishra BB, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, et al. 2010. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol. 12:1046-63
52. VolkmanHE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. 2010. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327:466-69
53. Brodin P, Rosenkrands I, Andersen P, Cole ST, Brosch R. 2004. ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 12:500-8 (Pubitemid 39370732)
54. Siegrist MS, Unnikrishnan M, McConnell MJ, Borowsky M, Cheng TY, et al. 2009. Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc. Natl. Acad. Sci. USA 106:18792-97
55. Serafini A, Boldrin F, Palù G, Manganelli R. 2009. Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: essentiality and rescue by iron and zinc. J. Bacteriol. 191:6340-44
56. Abdallah AM, Verboom T, Weerdenburg EM, Gey van Pittius NC, Mahasha PW, et al. 2009. PPE and PE-PGRS proteins of Mycobacterium marinum are transported via the type VII secretion system ESX-5. Mol. Microbiol. 73:329-40
57. Levine B, MizushimaN, VirginHW. 2011. Autophagy in immunity and inflammation. Nature 469:323-35
58. Collins CA, De Mazière A, van Dijk S, Carlsson F, Klumperman J, Brown EJ. 2009. Atg5-independent sequestration of ubiquitinated mycobacteria. PLoS Pathog. 5:e1000430
59. Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, et al. 2009. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host. Microbe 6:231-43
60. Harris J, DeHaro SA, Master SS, Keane J, Roberts EA, et al. 2007.Thelper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 27:505-17 (Pubitemid 47418681)
61. Xu Y, Jagannath C, Liu XD, Sharafkhaneh A, Kolodziejska KE, Eissa NT. 2007. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27:135-44 (Pubitemid 47089027)
62. DelgadoMA, Elmaoued RA, Davis AS, Kyei G, Deretic V. 2008. Toll-like receptors control autophagy. EMBO J. 27:1110-21 (Pubitemid 351508141)
63. Alonso S, Pethe K, Russell DG, Purdy GE. 2007. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. USA 104:6031-36 (Pubitemid 47175653)
64. Ponpuak M, Davis AS, Roberts EA, Delgado MA, Dinkins C, et al. 2010. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 32:329-41
65. Kumar D, Nath L, Kamal MA, Varshney A, Jain A, et al. 2010. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140:731-43
66. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, et al. 2008. Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS ONE 3:e1403
67. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondaneche MC, et al. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370-78 (Pubitemid 29159572)
68. Chan J, Xing Y, Magliozzo RS, Bloom BR. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-22
69. MacMicking JD, Taylor GA, McKinney JD. 2003. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 302:654-59 (Pubitemid 37310923)
70. Singh SB, Davis AS, Taylor GA, Deretic V. 2006. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313:1438-41 (Pubitemid 44360272)
71. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, et al. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704 (Pubitemid 37087769)
72. Pandey AK, Sassetti CM. 2008. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. USA 105:4376-80 (Pubitemid 351754388)
73. Chang JC, Miner MD, Pandey AK, Gill WP, Harik NS, et al. 2009. IGR genes and Mycobacterium tuberculosis cholesterol metabolism. J. Bacteriol. 191:5232-39
74. Yates RM, Hermetter A, Taylor GA, Russell DG. 2007. Macrophage activation downregulates the degradative capacity of the phagosome. Traffic 8:241-50 (Pubitemid 46656515)
75. Trost M, English L, Lemieux S, Courcelles M, Desjardins M, Thibault P. 2009. The phagosomal proteome in interferon-α-activated macrophages. Immunity 30:143-54
76. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-73
77. Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, et al. 2007. IFN-γ- and TNFindependent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol. 178:7190-98 (Pubitemid 46847445)
78. Liu PT, Stenger S, Tang DH, Modlin RL. 2007. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179:2060-63
79. Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, et al. 2010. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur. Respir. J. 36:1185-206
80. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol. 161:2636-41 (Pubitemid 28397084)
81. Clay H, Volkman HE, Ramakrishnan L. 2008. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29:283-94
82. Bekker LG, Moreira AL, Bergtold A, Freeman S, Ryffel B, Kaplan G. 2000. Immunopathologic effects of tumor necrosis factor-in murine mycobacterial infection are dose dependent. Infect. Immun. 68:6954-61 (Pubitemid 32463408)
83. Tobin DM, Vary JC Jr, Ray JP, Walsh GS, Dunstan SJ, et al. 2010. The Lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140:717-30
84. Agarwal N, Lamichhane G, Gupta R, Nolan S, Bishai WR. 2009. Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature 460:98-102
85. Stamm LM, Morisaki JH, Gao LY, Jeng RL, McDonald KL, et al. 2003. Mycobacterium marinum escapes from phagosomes and is propelled by actin-based motility. J. Exp. Med. 198:1361-68 (Pubitemid 37392481)
86. Davis JM, Ramakrishnan L. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136:37-49
87. Molloy A, Laochumroonvorapong P, Kaplan G. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Gúerin. J. Exp. Med. 180:1499-509
88. Keane J, Remold HG, Kornfeld H. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164:2016-20 (Pubitemid 30108758)
89. Hinchey J, Lee S, Jeon BY, Basaraba RJ, Venkataswamy MM, et al. 2007. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J. Clin. Investig. 117:2279-88 (Pubitemid 47219573)
90. Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, et al. 2007. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathog. 3:e110
91. Chen M, Divangahi M, Gan H, Shin DS, Hong S, et al. 2008. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205:2791-801
92. Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. 2010. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 11:751-58
93. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, et al. 2006. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat. Genet. 38:68-74 (Pubitemid 43011884)
94. Adams DO. 1976. The granulomatous inflammatory response. A review. Am. J. Pathol. 84:164-92
95. Puissegur MP, Lay G, Gilleron M, Botella L, Nigou J, et al. 2007. Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and β1 integrin-mediated pathway. J. Immunol. 178:3161-69 (Pubitemid 46333198)
96. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. 2002. Real-time visualization of Mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17:693-702 (Pubitemid 35477789)
97. Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F. 2004. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol. 6:423-33 (Pubitemid 38488935)
98. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, et al. 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir forM. tuberculosis persistence. PLoS Pathog. 4:e1000204
99. D'Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT. 2006. Mycobacterium bovis bacillus Calmette-Gúerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 176:3087-97
100. Lay G, Poquet Y, Salek-Peyron P, Puissegur MP, Botanch C, et al. 2007. Langhans giant cells from M. tuberculosis-induced human granulomas cannot mediate mycobacterial uptake. J. Pathol. 211:76-85 (Pubitemid 46092032)
101. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, et al. 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197:121-27 (Pubitemid 36110263)
102. Maglione PJ, Xu J, Chan J. 2007. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. J. Immunol. 178:7222-34 (Pubitemid 46847448)
103. Wolf AJ, Desvignes L, Linas B, Banaiee N, Tamura T, et al. 2008. Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205:105-15 (Pubitemid 351185719)
104. Randhawa PS. 1990. Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies. Pathology 22:153-55 (Pubitemid 20337272)
105. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, et al. 2006. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol. 8:218-32 (Pubitemid 43356045)
106. Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, Germain RN. 2008. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity 28:271-84
107. Roberts DM, Liao RP, Wisedchaisri G, Hol WG, Sherman DR. 2004. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J. Biol. Chem. 279:23082-87 (Pubitemid 38685612)
108. Rustad TR, Harrell MI, Liao R, Sherman DR. 2008. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3:e1502
109. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. 2008. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76:2333-40
110. Nambuya A, Sewankambo N, Mugerwa J, Goodgame R, Lucas S. 1988. Tuberculous lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda. J. Clin. Pathol. 41:93-96 (Pubitemid 18030516)
111. Lucas S, Nelson AM. 1994. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people. In Tuberculosis: Pathogenesis, Protection and Control, ed. BR Bloom, pp. 503-13. Washington, DC: ASM
112. Kwan C, Ernst JD. 2011. HIV and TB: a deadly human syndemic. Clin. Microbiol. Rev. 24:351-76
113. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N. Engl. J. Med. 345:1098-104
114. Iliopoulos A, Psathakis K, Aslanidis S, Skagias L, Sfikakis PP. 2006. Tuberculosis and granuloma formation in patients receiving anti-TNF therapy. Int. J. Tuberc. Lung Dis. 10:588-90 (Pubitemid 43667651)
115. Canetti G. 1955. The Tubercle Bacillus in the Pulmonary Lesion of Man: Histobacteriology and Its Bearing on the Therapy of Pulmonary Tuberculosis. New York: Springer
116. Gill WP, Harik NS, Whiddon MR, Liao RP, Mittler JE, Sherman DR. 2009. A replication clock for Mycobacterium tuberculosis. Nat. Med. 15:211-14
117. Sutcliffe IC, Harrington DJ. 2004. Lipoproteins of Mycobacterium tuberculosis: an abundant and functionally diverse class of cell envelope components. FEMS Microbiol. Rev. 28:645-59 (Pubitemid 39469923)
118. Hertz CJ, Kiertscher SM, Godowski PJ, Bouis DA, Norgard MV, et al. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166:2444-50 (Pubitemid 32173480)
119. Banaiee N, Kincaid EZ, Buchwald U, Jacobs WR Jr, Ernst JD. 2006. Potent inhibition of macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J. Immunol. 176:3019-27
120. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202:1715-24 (Pubitemid 41815877)
121. Velez DR, Wejse C, Stryjewski ME, Abbate E, HulmeWF, et al. 2010. Variants in Toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, andWest Africans. Hum. Genet. 127:65-73
122. Mayer-BarberKD, Barber DL, Shenderov K, White SD, Wilson MS, et al. 2010. Caspase-1-independent IL-1αproduction is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184:3326-30
123. Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, et al. 2008. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 181:7157-65
124. Gandotra S, Jang S, Murray PJ, Salgame P, Ehrt S. 2007. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 75:5127-34 (Pubitemid 350033599)
125. Schroder K, Tschopp J. 2010. The inflammasomes. Cell 140:821-32
126. McElvania Tekippe E, Allen IC, Hulseberg PD, Sullivan JT, McCann JR, et al. 2010. Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS ONE 5:e12320
127. Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, Schlesinger LS. 2010. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor linking mannose receptor recognition to regulation of immune responses. J. Immunol. 185:929-42
128. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. 2007. Ctype lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26:605-16 (Pubitemid 46756345)
129. Tanne A, Ma B, Boudou F, Tailleux L, Botella H, et al. 2009.AmurineDC-SIGNhomologue contributes to early host defense against Mycobacterium tuberculosis. J. Exp. Med. 206:2205-20
130. Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, et al. 2007. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J. Immunol. 179:3463-71
131. van de Veerdonk FL, Teirlinck AC, Kleinnijenhuis J, Kullberg BJ, van Crevel R, et al. 2010. Mycobacterium tuberculosis induces IL-17A responses through TLR4 and Dectin-1 and is critically dependent on endogenous IL-1. J. Leukoc. Biol. 88:227-32
132. Zenaro E, Donini M, Dusi S. 2009. Induction of Th1/Th17 immune response by Mycobacterium tuberculosis: role of Dectin-1, mannose receptor, and DC-SIGN. J. Leukoc. Biol. 86:1393-401
133. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, et al. 2009. Requisite role for the Dectin-1 α-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182:4938-46
134. Marakalala MJ, Guler R, Matika L, Murray G, Jacobs M, et al. 2011. The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in mice. Microbes Infect. 13:198-201
135. Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, et al. 2010. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med. 207:777-92
136. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. 2005. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J. Infect. 50:432-37 (Pubitemid 40692029)
137. Yamshchikov AV, Kurbatova EV, Kumari M, Blumberg HM, Ziegler TR, et al. 2010. Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am. J. Clin. Nutr. 92:603-11
138. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, et al. 2009. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 179:843-50
139. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, et al. 2011. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377:242-50
140. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, et al. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-β/. Proc. Natl. Acad. Sci. USA 98:5752-57 (Pubitemid 32435714)
141. Antonelli LR, Gigliotti Rothfuchs A, Goncalves R, Roffe E, Cheever AW, et al. 2010. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Investig. 120:1674-82
142. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. 2010. An interferon-inducible neutrophildriven blood transcriptional signature in human tuberculosis. Nature 466:973-77
143. Vankayalapati R, Wizel B, Weis SE, Safi H, Lakey DL, et al. 2002. The NKp46 receptor contributes to NKcell lysis ofmononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168:3451-57 (Pubitemid 34250410)
144. Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, et al. 2006. NK cell-derived IFN-γ differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177:7086-93 (Pubitemid 44715076)
145. Montoya CJ, Catano JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. 2008. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin. Immunol. 127:1-6
146. Chackerian A, Alt J, Perera V, Behar SM. 2002. Activation ofNKTcells protects mice from tuberculosis. Infect. Immun. 70:6302-9 (Pubitemid 35192722)
147. Sada-Ovalle I, Skold M, Tian T, Besra GS, Behar SM. 2010. α-Galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection. Am. J. Respir. Crit. CareMed. 182:841-47
148. Venkataswamy MM, Baena A, Goldberg MF, Bricard G, Im JS, et al. 2009. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Gúerin. J. Immunol. 183:1644-56
149. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, et al. 2010. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8:e1000407
150. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, et al. 2010. Antimicrobial activity of mucosalassociated invariant T cells. Nat. Immunol. 11:701-8
151. Moody DB. 2006. The surprising diversity of lipid antigens for CD1-restricted T cells. Adv. Immunol. 89:87-139
152. Wallgren A. 1948. The time-table of tuberculosis. Tubercle 29:245-51
153. Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-80 (Pubitemid 32524511)
154. Harding CV, Boom WH. 2010. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat. Rev. Microbiol. 8:296-307
155. Gallegos AM, Pamer EG, Glickman MS. 2008. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J. Exp. Med. 205:2359-68
156. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, et al. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-γresponses if IL-12p70 is available. J. Immunol. 175:788-95 (Pubitemid 41094960)
157. Desvignes L, Ernst JD. 2009. Interferon-α-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosis. Immunity 31:974-85
158. Kagina BM, Abel B, Scriba TJ, Hughes EJ, Keyser A, et al. 2010. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Gúerin vaccination of newborns. Am. J. Respir. Crit. CareMed. 182:1073-79
159. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonaryCD4+ Tcell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-77 (Pubitemid 46745412)
160. Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, et al. 2010. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J. Immunol. 184:4414-22
161. Blanco FC, Bianco MV, Meikle V, Garbaccio S, Vagnoni L, et al. 2011. Increased IL-17 expression is associated with pathology in a bovine model of tuberculosis. Tuberculosis 91:57-63
162. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. 2011. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 186:1598-607
163. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB. 2010. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207:1409-20
164. Chen X, Zhou B, Li M, Deng Q, Wu X, et al. 2007. CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol. 123:50-59 (Pubitemid 46420558)
165. Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK. 2009. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am. J. Respir. Crit. CareMed. 179:1061-70
166. Bruns H, Meinken C, Schauenberg P, Harter G, Kern P, et al. 2009. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Investig. 119:1167-77
167. Lewinsohn DA, Heinzel AS, Gardner JM, Zhu L, Alderson MR, Lewinsohn DM. 2003. Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells.Am. J. Respir. Crit. Care Med. 168:1346-52 (Pubitemid 37487330)
168. Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, et al. 2002. HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells. J. Exp. Med. 196:1473-81 (Pubitemid 35424941)
169. Joosten SA, vanMeijgaarden KE, vanWeeren PC, Kazi F, Geluk A, et al. 2010. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T cells with cytotoxic as well as regulatory activity. PLoS Pathog. 6:e1000782